Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 for Treatment of Hereditary Throm

americanpharmaceuticalreviewMarch 23, 2017

Tag: Shire , FDA

PharmaSources Customer Service